Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant.

Journal of comparative effectiveness research(2023)

引用 0|浏览15
暂无评分
关键词
abemaciclib,breast cancer,indirect comparison,palbociclib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要